Showing results (81-90 of 1,827) with videos related to
Sort By:
Pageof 183
ESMO Open|February 21, 2021
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trialA Camerini, A Morabito, A Montanino, et al.ESMO Open|September 27, 2019
Liquid biopsy assessment of synchronous malignancies: a case report and review of the literatureSandra Liebs, Anika Nonnenmacher, Frederick Klauschen, et al.ESMO Open|September 27, 2019
UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)Ines Vaz-Luis, Paul Cottu, Christel Mesleard, et al.ESMO Open|August 20, 2019
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancerJuan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, et al.ESMO Open|August 20, 2019
How I treat metastatic melanomaReinhard Dummer, Joanna Mangana, Anna Lisa Frauchiger, et al.ESMO Open|August 20, 2019
How I treat ALK-positive non-small cell lung cancerMichael G McCusker, Alessandro Russo, Katherine A Scilla, et al.ESMO Open|August 20, 2019
How we treat neurological toxicity from immune checkpoint inhibitorsLavinia Spain, Zayd Tippu, James M Larkin, et al.ESMO Open|December 20, 2021
Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trialS Branchoux, C L Sofeu, A-F Gaudin, et al.ESMO Open|November 28, 2021
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study programV Müller, M Banys-Paluchowski, T W P Friedl, et al.Pageof 183